Authors:
Moreno, D
Gourlet, P
De Neef, P
Cnudde, J
Waelbroeck, M
Robberecht, P
Citation: D. Moreno et al., Development of selective agonists and antagonists for the human vasoactiveintestinal polypeptide VPAC(2) receptor, PEPTIDES, 21(10), 2000, pp. 1543-1549
Authors:
Van Rampelbergh, J
Juarranz, MG
Perret, J
Bondue, A
Solano, RM
Delporte, C
De Neef, P
Robberecht, P
Waelbroeck, M
Citation: J. Van Rampelbergh et al., Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition, BR J PHARM, 130(4), 2000, pp. 819-826
Authors:
Di Paolo, E
Petry, H
Moguilevsky, N
Bollen, A
De Neef, P
Waelbroeck, M
Robberecht, P
Citation: E. Di Paolo et al., Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor, RECEPT CHAN, 6(4), 1999, pp. 309-315
Authors:
Di Paolo, E
De Neef, P
Moguilevsky, N
Petry, H
Cnudde, J
Bollen, A
Waelbroeck, M
Robberecht, P
Citation: E. Di Paolo et al., Properties of a recombinant human secretin receptor: A comparison with therat and rabbit receptors, PANCREAS, 19(1), 1999, pp. 51-55
Citation: Mg. Juarranz et al., Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes, PROSTATE, 41(1), 1999, pp. 1-6
Authors:
Juarranz, MG
Van Rampelbergh, J
Gourlet, P
De Neef, P
Cnudde, J
Robberecht, P
Waelbroeck, M
Citation: Mg. Juarranz et al., Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands, MOLEC PHARM, 56(6), 1999, pp. 1280-1287
Authors:
Juarranz, MG
Van Rampelbergh, J
Gourlet, P
De Neef, P
Cnudde, L
Robberecht, P
Waelbroeck, M
Citation: Mg. Juarranz et al., Vasoactive intestinal polypeptide VPAC(1) and VPAC(2) receptor chimeras identify domains responsible for the specificity of ligand binding and activation, EUR J BIOCH, 265(1), 1999, pp. 449-456